E2F1 and BRD2

  • Number of citations of the paper that reports this interaction (PMID 10965846)
  • 49
  • Data Source:
  • HPRD (in vivo)

E2F1

BRD2

Gene Name E2F transcription factor 1 bromodomain containing 2
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 70 interactors: ARID3A ATAD2 ATM ATR BRCA1 BRD2 BTRC CCNA1 CCNA2 CDK1 CDK2 CDK3 CDK7 CDKN2A CEBPE CHEK2 CREBBP CTDP1 CUL1 DDB2 E2F6 ERCC3 FHL2 GSK3B GTF2H1 HCFC1 IGF1 KAT5 KDM1A MDM2 MDM4 MGA MNAT1 MYBL2 NCOA3 NCOA6 NCOR2 NDN NDNL2 NFKB1 NPDC1 NRIP1 PARP1 PHB PKIB PRDM2 PURA RARA RB1 RNF144A SERTAD2 SETD7 SKP2 SP1 SP2 SP3 SP4 SPIB STAT1 STOML1 TBP TEAD3 TFDP1 TFDP2 TOPBP1 TP53 TP53BP1 TRRAP VHL YWHAQ 7 interactors: E2F1 E2F2 HIST1H4A HIST2H2BE HIST3H2BB HIST4H4 TBP
Entrez ID 1869 6046
HPRD ID 01806 03326
Ensembl ID ENSG00000101412 ENSG00000204256
Uniprot IDs Q01094 Q9BSD8 P25440 Q63HQ9 Q658Y7
PDB IDs 1H24 1O9K 2AZE 1X0J 2DVQ 2DVR 2DVS 2DVV 2E3K 2G4A 2YDW 2YEK 3AQA 3ONI 4A9E 4A9F 4A9H 4A9I 4A9J 4A9M 4A9N 4A9O 4AKN 4ALG 4ALH
Enriched GO Terms of Interacting Partners?
Tagcloud ?
box  coexpression  consensus  delays  displaying  dp  dps  e2fs  ectopic  emphasizes  exit  heterodimerization  heterodimers  lacks  members  namely  pocket  possesses  possessing  preference  quiescent  refer  shares  suppresses  transactivational  tttcccgc  tttcgcgc  unlike 
abc  bet  brd4  bromodomain  btk  constitutive  cytoplasm  diffuse  dlbcl  extraterminal  favorably  ibrutinib  ikappab  ikk  jq1  killing  maintaining  mechanistic  modulators  oncogenic  platform  programs  screen  sustained  synergized  synergy  throughput  unexpected  xenograft 
Tagcloud (Difference) ?
box  coexpression  consensus  delays  displaying  dp  dps  e2fs  ectopic  emphasizes  exit  heterodimerization  heterodimers  lacks  members  namely  pocket  possesses  possessing  preference  quiescent  refer  shares  suppresses  transactivational  tttcccgc  tttcgcgc  unlike 
abc  bet  brd4  bromodomain  btk  constitutive  cytoplasm  diffuse  dlbcl  extraterminal  favorably  ibrutinib  ikappab  ikk  jq1  killing  maintaining  mechanistic  modulators  oncogenic  platform  programs  screen  sustained  synergized  synergy  throughput  unexpected  xenograft 
Tagcloud (Intersection) ?